James Mark Cleary

Suggest Changes
Learn More
3005^ Background: The RAS/RAF/MEK and PI3K/AKT signaling pathways are both deregulated in many tumor types. Targeting both pathways may be more efficacious than targeting either pathway alone. In(More)